Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Cui J, Philo L, Nguyen P, Hofflich H, Hernandez C, Bettencourt R, Richards L, Salotti J, Bhatt A, Hooker J, Haufe W, Hooker C, Brenner DA, Sirlin CB, Loomba R.
Cui J, et al. Among authors: philo l.
J Hepatol. 2016 Aug;65(2):369-76. doi: 10.1016/j.jhep.2016.04.021. Epub 2016 May 2.
J Hepatol. 2016.
PMID: 27151177
Free PMC article.
Clinical Trial.